U.S. Drug Discovery Contract Research Organization Markets

Table of Contents

• 1. Executive Summary
  • 1. Executive Summary
    • 1. Executive Summary
• 2. Overview
  • 1. Overview
    • 1. Introduction
    • 2. Market Segmentation
    • 3. Research Methodology
    • 4. Market Engineering Measurements
• 3. U.S. Drug Discovery Contract Research Organization Markets
  • 1. Market Drivers Restraints and Trends
    • 1. Market Drivers
    • a. Cost Pressures Encourage Research and Development (R&D) Outsourcing
    • b. Strong Growth of R&D Expenditure by Pharmaceutical and Biotechnology Companies Spurs Market Expansion
    • c. Aging Population and Shift from Acute to Chronic Products Drives Demand for Outsourcing
    • d. Limited Development Infrastructure with Biotechnology and Specialty Pharmaceutical Encourages Demand for Outsourcing
    • e. Robust Biotechnology Funding Drives Outsourcing Volumes
    • f. Toxicology Capacity Addition by Outsourcers Encourages Outsourcing Market Expansion
    • 2. Market Restraints
    • a. Increasing Competition and Commoditization of CRO Services Curtails Margins
    • b. Increasingly Stringent Regulatory Standards Pose an Ongoing Quality Challenge for CROs
    • c. Consolidation of the Pharmaceutical Industry Reduces Potential Revenues for Contract Research
    • d. Small CRO Size Limits Breadth of Offerings, While, Large Size Limits Flexibility
    • 3. Market Trends
  • 2. Revenue Forecasts Demand Analysis and Competitive Structure
    • 1. Revenue Forecasts
    • 2. Demand Analysis
    • 3. Competitive Structure
  • 3. Competitive Analysis
    • 1. Market Share Analysis
  • 4. Frost and Sullivan Awards
    • 1. Business Development Strategy Leadership Award
    • 2. Growth Strategy Leadership Award
    • 3. Market Leadership Award
• 4. Challenges and Strategies
  • 1. Industry Challenges & Strategies
    • 1. Industry Challenges
    • 2. Strategies
• 5. Decision Support Databases
  • 1. Pharmaceuticals and Biotechnology
    • 1. Pharmaceutical Research and Development Expenditure
    • 2. Biotechnology Companies
    • 3. Private Investment in Biotechnology Companies
    • 4. Biotechnology Government Research and Development Expenditure
  • 2. Macro Economic and Demographic Indicators
    • 1. Nominal GDP Growth
    • 2. Total Population